Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vittoria Palmieri

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|October 10, 2013
Prostamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibitionAlessia Ligresti, Jose Martos, Jenny Wang, et al.
Frontiers in Immunology|August 2, 2021
IL-33 Drives Expansion of Type 2 Innate Lymphoid Cells and Regulatory T Cells and Protects Mice From Severe, Acute ColitisNhi Ngo Thi Phuong, Vittoria Palmieri, Alexandra Adamczyk, et al.
Journal of Crohn'S & Colitis|October 9, 2018
Colitis Alters Oxysterol Metabolism and is Affected by 4β-Hydroxycholesterol AdministrationOwein Guillemot-Legris, Valentin Mutemberezi, Baptiste Buisseret, et al.
European Journal of Medicinal Chemistry|August 26, 2016
Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptorJavier Romero-Parra, Jaime Mella-Raipán, Vittoria Palmieri, et al.
Mucosal Immunology|March 3, 2021
Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunityVittoria Palmieri, Jana-Fabienne Ebel, Nhi Ngo Thi Phuong, et al.
Cell Reports. Medicine|March 18, 2025
Microbiota-produced immune regulatory bile acid metabolites control central nervous system autoimmunityMartina Antonini Cencicchio, Federico Montini, Vittoria Palmieri, et al.
Frontiers in Immunology|July 6, 2019
Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven ColitisJana Meiners, Vittoria Palmieri, Robert Klopfleisch, et al.
Mucosal Immunology|June 6, 2019
The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancerEva Pastille, Marie-Hélène Wasmer, Alexandra Adamczyk, et al.
Ebiomedicine|April 16, 2023
Alterations of the intestinal mucus layer correlate with dysbiosis and immune dysregulation in human Type 1 DiabetesMarta Lo Conte, Ilaria Cosorich, Roberto Ferrarese, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|October 10, 2013
Prostamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibitionAlessia Ligresti, Jose Martos, Jenny Wang, et al.
Frontiers in Immunology|August 2, 2021
IL-33 Drives Expansion of Type 2 Innate Lymphoid Cells and Regulatory T Cells and Protects Mice From Severe, Acute ColitisNhi Ngo Thi Phuong, Vittoria Palmieri, Alexandra Adamczyk, et al.
Journal of Crohn'S & Colitis|October 9, 2018
Colitis Alters Oxysterol Metabolism and is Affected by 4β-Hydroxycholesterol AdministrationOwein Guillemot-Legris, Valentin Mutemberezi, Baptiste Buisseret, et al.
European Journal of Medicinal Chemistry|August 26, 2016
Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptorJavier Romero-Parra, Jaime Mella-Raipán, Vittoria Palmieri, et al.
Mucosal Immunology|March 3, 2021
Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunityVittoria Palmieri, Jana-Fabienne Ebel, Nhi Ngo Thi Phuong, et al.
Cell Reports. Medicine|March 18, 2025
Microbiota-produced immune regulatory bile acid metabolites control central nervous system autoimmunityMartina Antonini Cencicchio, Federico Montini, Vittoria Palmieri, et al.
Frontiers in Immunology|July 6, 2019
Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven ColitisJana Meiners, Vittoria Palmieri, Robert Klopfleisch, et al.
Mucosal Immunology|June 6, 2019
The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancerEva Pastille, Marie-Hélène Wasmer, Alexandra Adamczyk, et al.
Ebiomedicine|April 16, 2023
Alterations of the intestinal mucus layer correlate with dysbiosis and immune dysregulation in human Type 1 DiabetesMarta Lo Conte, Ilaria Cosorich, Roberto Ferrarese, et al.
Pageof 1